Continuous infusion therapy after deep brain stimulation in Parkinson's disease: indications, outcomes, and patient selection. (PubMed, J Neural Transm (Vienna)) - Sep 29, 2026 - "They report 118 patients and 119 infusion courses: 68 with intestinal levodopa gel, 23 with apomorphine, 28 with foslevodopa/foscarbidopa, and none with entacapone...Infusion therapy may help recurrent levodopa-responsive complications after stimulation has been re-evaluated and optimized. Its use in late axial or cognitive decline is untested rather than disproven."
Journal • Review • CNS Disorders • Movement Disorders • Parkinson's Disease
|